In Brief


Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for Nov. 2021
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.For further information, contact the principal investigator listed.
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- AACI letter to NIH’s Bhattacharya opposes centralizing review of CCSG